ARCHIVES

Chemopreventive Phase I, Preclinical Studies Concept Approved

This article is from The Cancer Letter archive.

Vol. 09 No. 19 | May 13, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Administration To Hold ASSIST Funding To ’92 Level; ACS Says Result Is Percent Cut

March 20, 1992

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998